Ive never seen an company PR / 8-K with more substance than
Ive never seen an company PR / 8-K with more substance than the one GRST placed on 12/10/20. There were 13 separate announcements in one PR / 8K.
Listing it as an 8K sends a very strong message. They're extremely confident in the content and invite the SEC to examine whatever they please.
The company has plans to build a substance abuse treatment group with over 1000 beds of capacity. GRST has the strong potential for well over a dollar value per share as they have stated they will list on NASDAQ and won't have any reverse splits until they have listed.
I posted the below with regard to their PR on the 10th:
1- Update on Labrys Fund LP updated warrant price from .0015 to .00205.
Over a 36% price improvement for shareholders.
2- Warrants issued, 100,000,000 instead of 183,333,333.
An 83% improvement on issued warrants for shareholders.
3- CEO cancels 1,757,850 personal shares. CEO has never sold any of his personal shares.
Mr. Leon is concerned about outstanding shares and dilution, contrary to some posts on this board. This PR sets Mr. Leon apart from virtually every other CEO on the OTC.
4- CEO hasn't charged The Company any fees directly or indirectly for the last two years.
I would wager Mr. Leon continues to receive income from the families billion+ dollar business since he is forgoing any compensation from ARIA for such a lengthy period.
5- The Company will be very strategic with any share issuance going forward.
For the prevaricating posters screaming DILUTION. I like the word strategic, expansion?
6- Once the Company gets the convertible debt repaid with equity or fixed price debt, it will seek shareholder approval to significantly reduce the authorized shares outstanding.
Fixed price debt please. Shareholder input on authorized share reduction, unheard of.
7- The Company has previously announced the plans to file a Form 1-A under Regulation A to raise funding for acquisitions and to repay some of the current debt. The Company expects to make the filing soon.
Borrowing money instead of diluting shares. Should be easy to pay back with tens of millions of dollars in annual revenue.
8- ARIA commenced its Audit with the Department of Children and Families (“DCF”) today and is expected to complete the audit successfully in the next several days. This will give ARIA its full license...
Compliant with all business regulations. Open for more business immediately. News very soon.
9- This will give ARIA its full license and the ability to finalize contracts with certain insurance providers that will broadly expand the range of clients it can serve.
More insurance money available for patients. In another quarter, will have the revenue of an OTCQX at the price of a Pink with a stop sign. We are grossly undervalued.
10- ARIA received its LegitScript approval recently.
Certified that they are compliant with all laws and regulations for a substance abuse treatment center. Advertising on a national basis. A highly professional organization with all its growth ahead.
11- Received approval by Google to begin Pay Per Click (“PPC”) marketing. The PPC campaign commenced yesterday.
In business, no covid-19 problems and advertising for patients NATIONWIDE!
12- ARIA was pleased with the number of clients that it admitted in the first month of business and expects to boost those numbers with the PPC campaign.
I think the startup client traffic and accompanying revenue lead Mr. Leon to consider getting a loan to reduce current debt and to EXPAND.
13- ARIA has had a great success in managing the spread of Covid-19 at the new facility and attributes that success to the use of the Covid Clear product in the treatment of the facility environment ARIA has managed to keep the staff and clients free from the virus to date.
The side business keeps ARIA in business and illness free. A huge win win.
We have a lot to look forward to from this PR both in forthcoming news and in valuation.
4
Scroll down for more posts ▼
Top 10 Most Recent News Articles
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Top 5 Most Recently Viewed Articles
Ares Capital got traders buzzing back when it offered a solid yield of around 9%. It stood out as the largest publicly traded business development company (BDC) globally, which made income-focused investors take notice. But here’s the kicker: BDCs like Ares can sidestep corporate taxes if they hand out most of their earnings as dividends, creating a prime hunting ground...
Continue Reading
Keurig Dr Pepper Welcomes New Chief Financial Officer Keurig Dr Pepper (NASDAQ: KDP) recently announced an exciting leadership change with the appointment of Anthony DiSilvestro as its new Chief Financial Officer. This important transition marks a significant step as DiSilvestro steps into his role immediately, bringing over four decades of extensive experience across...
Continue Reading
Elisa Unveils Elisa Industriq: A New Era in Software Solutions Elisa Oyj is excited to announce a significant milestone as it consolidates its international digital services under a unified brand known as Elisa Industriq. This initiative aims to streamline its software offerings and create a robust identity within the market. Following this change, Elisa will report the...
Continue Reading
Driving Community Support Through Strategic Grants The American Water Charitable Foundation and Illinois American Water are making waves by putting their money where their mouth is, delivering a batch of state strategic impact grants to United Way organizations that promise to spark some serious change. It’s not every day you see such a duo diving into local communities...
Continue Reading
Essity Faces Early Bond Repayment Demand Amid Dispute Essity has found itself in a challenging situation. Recently, a handful of bondholders have made a demand for the early repayment of bonds that are set to mature in the upcoming years of 2029, 2030, and 2031. This unexpected request has prompted Essity to reaffirm its position and contest the claims of these...
Continue Reading